Patents by Inventor Rohitha SriRamaratnam

Rohitha SriRamaratnam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncogenic-RAS-signal dependent lethal compounds
    Patent number: 8546421
    Abstract: Compounds with cancer cell specific lethality are provided. In particular, RAS-selective lethal compounds and compositions are provided. Also provided are methods of screening for such compounds and methods of treating a condition in a mammal, by administering to the mammal a therapeutically effective amount of such compounds or compositions.
    Type: Grant
    Filed: August 21, 2009
    Date of Patent: October 1, 2013
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Brent R. Stockwell, Wan Seok Yang, Rohitha Sriramaratnam
  • Oncogenic-RAS-signal dependent lethal compounds
    Publication number: 20100081654
    Abstract: Compounds with cancer cell specific lethality are provided. In particular, RAS-selective lethal compounds and compositions are provided. Also provided are methods of screening for such compounds and methods of treating a condition in a mammal, by administering to the mammal a therapeutically effective amount of such compounds or compositions.
    Type: Application
    Filed: August 21, 2009
    Publication date: April 1, 2010
    Inventors: Brent R. Stockwell, Wan Seok Yang, Rohitha SriRamaratnam